Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02743117 · ClinicalTrials.gov registry record · Phase 4

Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2016-2017 Season

A Phase 4 study of Healthy and Influenza, sponsored by MedImmune.

Completed
Registry status
Phase 4
Development phase
301
Enrollment target
3
Study locations

NCT02743117 is a Phase 4 study of Healthy and Influenza that has completed, run by MedImmune. The registered enrollment target is 301 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (53% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02743117, a Phase 4 study of Healthy and Influenza, has completed, sponsored by MedImmune.

COMPLETED
Registry status
Phase 4
Development phase
301 participants
Enrollment target
3
Study locations

Study Summary

This prospective annual release study is designed to evaluate the safety of 1 new influenza virus vaccine strain to be included in FluMist Quadrivalent for the 2016-2017 influenza season

Conditions Studied

Healthy Influenza

Interventions

  • OTHER Placebo
  • BIOLOGICAL Monovalent Influenza Vaccine

Study Locations (3)

Florida

  • Research Site - South Miami

Georgia

  • Research Site - Stockbridge

Oregon

  • Research Site - Portland

Trial Details

FieldValue
Enrollment Target 301 participants
Start Date 2016-05-02
Est. Completion 2016-11-30
Phase Phase 4

Sponsor

MedImmune

210 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02743117

The ClinicalTrials.gov registry entry for NCT02743117 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 301 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (53% lower). The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02743117 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Georgia, Oregon.

Frequently Asked Questions

What is clinical trial NCT02743117 about?

NCT02743117 is a clinical study titled "Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2016-2017 Season". This prospective annual release study is designed to evaluate the safety of 1 new influenza virus vaccine strain to be included in FluMist Quadrivalent for the 2016-2017 influenza season

What is the current status of trial NCT02743117?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 301 participants. The study started on 2016-05-02. Estimated completion is 2016-11-30.

What conditions does trial NCT02743117 study?

This clinical trial studies the following conditions: Healthy, Influenza.

What interventions are being tested in trial NCT02743117?

The interventions under investigation include: Placebo (OTHER), Monovalent Influenza Vaccine (BIOLOGICAL).

Who is sponsoring clinical trial NCT02743117?

This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02743117 being conducted?

This trial has 3 study locations across Florida, Georgia, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Influenza

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.